Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net income	$ 342,989	$ 234,579	$ 142,407
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	169,231	132,328	128,168
Deferred income taxes	32,074	31,040	7,583
(Gain) loss on disposition of assets	(190)	1,137	(1,131)
Share-based compensation	34,693	28,588	17,578
Excess tax benefit from share-based compensation	(4,031)	(3,622)	0
Non-cash interest expense	2,780	2,180	8,500
Non-cash increase (reduction) in contingent consideration	1,577	0	(22,100)
(Increase) decrease in:
Receivables, net	(138,257)	(114,354)	(114,847)
Inventories	(89,184)	(67,400)	(72,810)
Other current assets	(100,438)	10,391	(46,695)
Pre-production and development costs	(24,873)	7,821	(23,708)
Increase (decrease) in:
Accounts payable	273,627	147,994	(23,394)
Accrued warranties	32,971	21,061	28,723
Accrued other liabilities	47,851	127,950	12,558
Income taxes payable	52,579	12,609	(3,026)
Net change in derivative assets and liabilities	(55,246)	18,121	(562)
Other operating activities	(25,550)	1,717	4,892
Net cash provided by operating activities	552,603	592,140	42,136
Cash flows from investing activities:
Acquisitions, net of cash received	(556,475)	(422,953)	(104,735)
Capital expenditures	(192,498)	(157,141)	(101,682)
Purchases of short-term investments	0	0	(73,761)
Maturities of short-term investments	0	10,008	267,278
Proceeds from asset dispositions	4,552	0	3,944
Purchase of investments for irrevocable trust	5,005	(42,400)	0
Other items, net	950	434	(1,735)
Net cash used in investing activities	(738,466)	(612,052)	(10,691)
Cash flows from financing activities:
Decrease in short-term borrowings	(2,569)	(1,162)	(36,590)
Borrowings of long-term debt	1,068,892	300,000	300,000
Repayments of long-term debt	(552,298)	(30,000)	(424,079)
Debt issuance costs	(9,668)	0	(6,094)
Cash dividends to shareholders	(92,600)	(83,053)	(41,449)
Repurchase of common stock	0	(90,779)	(5,398)
Exercise of stock options	27,676	48,626	20,149
Repurchases related to share-based compensation arrangements	(22,318)	(12,316)	(6,210)
Excess tax benefit from share-based compensation	4,031	3,622	0
Payment of contingent consideration	(327)	0	0
Repayments of acquiree debt	(121,198)	0	0
Other items, net	5,565	1,666	(3,740)
Net cash provided by (used in) financing activities	305,186	136,604	(203,411)
Effect of exchange rate changes on cash	(51,122)	10,362	8,868
Net increase (decrease) in cash and cash equivalents	68,201	127,054	(163,098)
Cash and cash equivalents at beginning of period	581,312	454,258	617,356
Cash and cash equivalents at end of period	649,513	581,312	454,258
Non-cash investing activities:
Accrued and contingent acquisition-related liabilities	280,346	13,384	1,488
Common stock issued in connection with acquisitions	$ 316,035	$ 0	$ 0